Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yulan Capital Management is a New York-based investment management firm that specializes in the global healthcare and consumer sectors, with a strategic emphasis on the Greater China market. Established in 2013 by Lihua (Lilly) Huang, the firm utilizes a fundamental, bottom-up research process to invest in public and private companies across the biotechnology, pharmaceutical, and medical technology industries. Yulan Capital is recognized for its expertise in identifying cross-border investment opportunities and navigating complex regulatory environments in both Asia and the West. The firm manages a variety of investment vehicles, including hedge funds and private equity-style accounts, aimed at institutional clients. By leveraging deep industry knowledge, Yulan Capital seeks to capitalize on the rapid innovation and demographic shifts driving the healthcare sector globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yulan Capital Management.